IMPACT OF EGFR MUTATION ON PROGNOSIS OF STAGE IV NON-SQUAMOUS NON-SMALL CELL LUNG CANCER NSCLC: A RETROSPECTIVE ANALYSIS
Background: Patients with activating somatic mutations in the Epidermal Growth Factor Receptor (EGFR) have better prognosis when treated with Tyrosine Kinase Inhibitors (TKI) as the standard treatment of care in advanced stage NSCLC.Aim of the work: To study the impact of EGFR mutation on prognosis...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ain Shams University; Faculty of Medicine. Ain Shams Clinical and Scientific Society
2023-06-01
|
| coleção: | Ain Shams Medical Journal |
| Assuntos: | |
| Acesso em linha: | https://asmj.journals.ekb.eg/article_307098_fc9aac9b0d5f6c6b551e314d913941be.pdf |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|